Clinical Trial Update: GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating GTN therapy effects on biomarkers of immune escape in men with biochemical recurrence of prostate cancer after primary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GTN therapy

Snippet

Sponsor: Dr. D. Robert Siemens | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED